Patents
Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
07/2008
07/24/2008WO2008088487A2 Phosphorus-sulfur fr additives and polymer systems containing same
07/24/2008US20080176852 Biguanide and dihydrotriazine derivatives
07/24/2008US20080176842 N1-[1-[N-(2-methylpropyl)-N-(phenylsulfonyl)amino]-2R-hydroxy-3S-(phenylmethyl)prop-3-yl]-3-(1-morpholinosulfonyl)-2R-methylpropionamide; viricide; human T-cell leukemia/limphoma virus
07/24/2008CA2676437A1 Substituted 1,3-dioxanes and their uses
07/24/2008CA2676435A1 Substituted 1,3-dioxanes useful as ppar modulators
07/24/2008CA2673524A1 Phosphorus-sulfur fr additives and polymer systems containing same
07/23/2008EP1945689A1 Process for producing trioxane and at least one comonomer
07/22/2008US7402685 includes a step of acetalizing hydroxypivalaldehyde with trimethylolpropane in a solvent in the presence of an acid catalyst; easy to handle and involves little danger of dust explosion
07/16/2008EP1943238A1 Preparation of cyclic, ketalized ketones by favorskii rearrangement and the use thereof for the preparation of glucokinase activator 70
07/16/2008CN101220019A Production method of diethyleno dioxide
07/16/2008CN100402120C Reactor for gas/liquid or gas/liquid/solid reactions
07/15/2008US7399505 Nematic or cholesteric or chiral-smectic; high absolute values of dielectric anisotropy combined with a favorable ratio of viscosity to clearing point; light- and UV-stable, and also thermally stable; high voltage holding ratio
07/15/2008CA2279620C 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4)
07/10/2008WO2008080824A1 Aromatic sulfonated ketals
07/10/2008WO2008080823A1 Reduction methodologies for converting ketal acids, salts, and esters to ketal alcohols
07/10/2008WO2008080822A1 Epimerization methodologies for recovering stereo isomers in high yield and purity
07/09/2008CN101218223A Benzodioxane and benzodioxolane derivatives and uses thereof
07/09/2008CN100400489C Production technology of bi-tribydroxy methyl propane and/or trihydroxy methyl propane methylal
07/08/2008US7396831 Vanilloid receptor ligands and their use in treatments
07/08/2008CA2373974C Treatment of a composition comprising a trimethylolalkane bis-monolinear formal
07/03/2008WO2008078762A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
07/03/2008WO2007107276A3 Process for preparing c7 intermediates and their use in the preparation of n-substituted pyrrole derivatives
07/03/2008US20080161583 Epimerization methodologies for recovering stereoisomers in high yield and purity
07/03/2008US20080161580 Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for the production and the use
07/03/2008US20080161563 Reducing ketal acid with a hydride reducing agent in a hydrophobic solvent to a ketal alcohol, quenching the reduction reaction;washing, extracting the ketal alcohol into the back-extracting hydrophobic solvent
07/03/2008US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome
07/03/2008US20080161223 (1R,2S,2' S,4R,5 'S)-1,2',5',7,7-pentamethylspiro[bicyclo[2.2.1]heptane-2,4'-[1,3]dioxane]; fine perfumery, household products, e.g. detergents for dishwashers, surface cleaners, laundry products, body care products, e.g. shampoo, cosmetics
07/03/2008US20080160627 Environmental Sensitive Fluorogenic Compounds and Their Application for Singlet Oxygen and Protein Detection
07/03/2008CA2674548A1 Novel n-(2-aminophenyl) benzamide derivative having urea structure
07/02/2008EP1939193A1 Process for purifying acetal compounds
07/02/2008CN100398543C Method of preparing fugutoxin water extract
06/2008
06/26/2008WO2008075353A1 Sulfonamide derivatives with therapeutic indications
06/26/2008WO2008075165A1 Novel process for the synthesis of [r-(r*, r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid or a pharmaceutically acceptable salt thereof
06/26/2008US20080153902 E.g., 2 N-(2-Fluorophenyl)-5(S)-amino-4(S)-hydroxy-2(S)-isopropyl-7(S)-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide; renin inhibitors used for the treatment of hypertension, heart failure, glaucoma, myocardial infarction, kidney failure, restenoses or stroke
06/26/2008CA2695613A1 Sulfonamide derivatives with therapeutic indications
06/25/2008EP1935879A1 Substituted cycloalkene derivative
06/25/2008EP1934188A2 Alpha, alpha`-dihydroxy ketone derivatives and use thereof as uv filter
06/25/2008EP1933820A2 Palmarumycin based inhibitors of thioredoxin and methods of using same
06/25/2008CN101204401A Sea hedgehog extractive, preparation method and anticancer application thereof
06/24/2008US7390833 osteoarthritis; compounds inhibit Aggrecanase Activity of a disintegrin and metalloprotease with thrombosondin type I motifs; biaryl sulfonamid derivatives; N-({4'-[2-4-methylisoquinolin-3-yl)ethyl]-1,1 '-biphenyl-4-yl}sulfonyl)-D-valine
06/24/2008US7390803 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; monocyte chemoattractant protein (MCP) receptor antagonist; antiinflammatory agent; antiallergen; autoimmune diseases; rhinitis, dermatitis, asthma
06/19/2008US20080146822 Stable lactide particles
06/19/2008US20080146533 Containing tertiary amine linked pyrrolidine, azetidine, morpholine or piperidine group; inhibiting GlyCer synthase, lowering glycosphingolipid levels; collagen vascular diseases, atherosclerosis, diabetic renal hypertrophy
06/18/2008EP0885210B2 Tricylic compounds having binding affinity for melatonin receptors, their production and use
06/18/2008CN101203500A Substituted arylamine compounds and uses as 5-HT6 moderator thereof
06/18/2008CN101200462A Ring aliphatic carbonate monomer, polymer and preparation method thereof
06/17/2008CA2305564C Process for the preparation of optically active 2-[6-(hydroxymethyl)-1,3-dioxan-4-yl]acetic acid derivatives
06/12/2008WO2008067911A1 Biphenyl-substituted spirocyclic ketoenols
06/12/2008CA2671179A1 Biphenyl-substituted spirocyclic ketoenols
06/11/2008CN101198586A Biphenyl and naphthyl-phenyl hydroxamic acid derivatives
06/10/2008US7385067 Process for the preparation of compounds having a CF2O bridge
06/10/2008US7384974 effective in reducing triglyceride levels in the liver and reducing blood glucose levels
06/05/2008US20080132716 Fluorophenyl compounds for liquid-crystalline mixtures
06/05/2008US20080132715 obtained via a flaking process, continuous flow of molten lactide cooled on drum or belt flaker, solidifies; Stored and transported at room temperature; high quality for use as polylactic acid starting material; racemization, hydrolysis and oxidation are prevented
06/05/2008US20080132459 Inhibitors of Histone Deacetylase
06/04/2008CN101193960A Blends of polyolefin additive compositions and articles
06/04/2008CN101190911A N-[2-(5,5-dimethyl-1,3-dioxan-2-yl)-ethyl]amino acid and its synthesis and application
06/03/2008US7381749 Sulfonamides as inhibitors of histone deacetylase for the treatment of disease
05/2008
05/29/2008WO2008061871A1 Ketomethionine ketals and their derivatives
05/29/2008WO2008061821A1 Process for preparing tetramethyl glycolide
05/29/2008US20080125599 obtained via a flaking process, continuous flow of molten lactide cooled on drum or belt flaker, solidifies; Stored and transported at room temperature; high quality for use as polylactic acid starting material; racemization, hydrolysis and oxidation are prevented
05/29/2008US20080125465 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
05/29/2008US20080124426 Ketomethionine ketals and derivatives thereof
05/29/2008DE102006055427A1 Verfahren zur Herstellung von Tetramethylglycolid A process for preparing tetramethyl glycolide
05/29/2008CA2669893A1 Ketomethionine ketals and their derivatives
05/28/2008EP1768954A4 2-methylpropanamides and their use as pharmaceuticals
05/28/2008CN101186603A Process for preparing tetramethyl glycolide
05/28/2008CN100390177C Preparation method of 6-cyano-7-methyl-1,1-(2,2-dimethyl-1,3-propylidine dioxy)-5-oxo-1,2,3,5-tetrahydro indolidin (I)
05/22/2008WO2008058402A1 Compounds and methods for treating protein folding disorders
05/22/2008WO2007133751A3 Base-stabilized polyorthoester formulations
05/22/2008US20080119547 Treating of a psychological disorder by administering a 3-Benzo[1,3]dioxol-5-yl-indan-1-yl)-dimethylamine or analogous 1,3-dithio, 1-oxa-3-thio ring derivatives; antidepressants; anxiolytic agents; post traumatic stress disorder, obsessive compulsive disorder, panic disorder, panic attacks, phobias
05/22/2008US20080119511 such as 3-(2-Methyl-2H-1,2,4-triazol-3-yl)-3-[4-(4'-trifluoromethyl-biphenyl-3-ylmethoxy)-phenyl]-propionic acid; G-protein coupled receptor modulator; antidiabetic and hypoglycemic agent; non-insulin dependent diabetes, obesity, hyperglycemia, glucose intolerance, hypertension, cardiovascular disease
05/22/2008CA2668744A1 Compounds and methods for treating protein folding disorders
05/21/2008EP1395551B1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
05/21/2008CN100389112C cyclic acetal and ketal compound and application thereof
05/20/2008US7375093 Nuclear receptor-based inducible gene expression system
05/15/2008US20080114061 Diphenylethylene compounds and uses thereof
05/15/2008US20080113968 Substituted piperazines and diazepanes
05/14/2008EP1919879A1 9-aminocarbonylsubstituted derivatives of glycylcyclines
05/14/2008EP1603860A4 Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
05/14/2008CN101180288A Aromatic substituted pentadienoic acid amide for combination with anti-infective drugs
05/14/2008CN100387592C Process for preparing lactide using microwave radiation pressure reducing catalystic method
05/07/2008EP1020458B1 Optically active 1,4-benzodioxine-2-carboxylic acid derivatives and process for producing the same
05/07/2008CN101176037A Photochromic materials having extended pi-conjugated systems and compositions and articles including the same
05/06/2008US7368585 Protected trihydroxyisoalkatrienyltriphenylphosphonium halides for proparing polyhydroxylactones; acid stable protecting groups include p-methoxybenzyl and tert-butyldimethylsilyl.
05/06/2008US7368568 Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for production and the use
05/06/2008US7368567 Arylsulfonyl benzodioxanes, benzoxazines and benzothiazines as 5-HT6 antagonists
05/06/2008US7368101 Process for the preparation of iopamidol and the new intermediates therein
05/06/2008CA2280727C Bicyclic amino acids
05/06/2008CA2244979C Proton conductor in liquid form
05/02/2008WO2008052086A1 Benzodioxane derivatives and uses thereof
05/01/2008US20080103113 Reduced level of background gene expression; responds to submicromolar concentrations of nonsteroidal ligand
04/2008
04/30/2008DE19933175B4 Schwefelpentalfurorid-Derivate und Verwendung für ein flüssigkristallines Medium Schwefelpentalfurorid derivatives and use for a liquid-crystalline medium
04/30/2008CN101171230A Heterocyclic-substituted alkanamides useful as renin inhibitors
04/30/2008CN101171003A Cytokine modulators using cyclic glycerides of essential poyunsaturated fatty acids
04/29/2008US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives
04/29/2008US7365085 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
04/24/2008WO2008047651A1 Process for production of flake-like dried 2-(5-ethyl-5-hydroxymethyl-1,3-dioxan-2-yl)-2-methylpropan-1-ol
04/24/2008WO2007138485A3 Ppar modulators
04/24/2008US20080097113 Method for the Production of a-(Alpha-Hydroxyalkyl)-1,3 Dioxan-5-Ones
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 103